Position in AMGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$85,799,678
+$11,129,139 QoQ
Shares Held
243,853
+6.9% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $434,660,167 across 16 Drug Manufacturers - General names. AMGN ranks #1 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
243,853 | $85,799,678 | |
| 2 | NVS |
Novartis AG
|
403,774 | $61,676,478 | |
| 3 | LLY |
ELI LILLY & Co
|
60,441 | $55,591,818 | |
| 4 | AZN |
Astrazeneca PLC
|
191,107 | $37,690,122 | |
| 5 | JNJ |
Johnson & Johnson
|
139,822 | $34,178,089 | |
| 6 | MRK |
Merck & Co., Inc.
|
232,295 | $27,942,765 | |
| 7 | GSK |
GSK plc
|
480,636 | $26,526,300 | |
| 8 | SNY |
Sanofi
|
509,464 | $24,545,975 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,799,678 | 243,853 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $74,670,539 | 228,134 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $60,332,384 | 213,793 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $56,653,663 | 202,907 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $54,822,830 | 175,968 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $76,620,340 | 293,970 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $89,758,361 | 278,571 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $85,795,020 | 274,588 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $78,837,102 | 277,283 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $78,744,091 | 273,398 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $74,448,132 | 277,006 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $59,971,598 | 270,118 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $67,110,767 | 277,604 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $70,774,388 | 269,473 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $59,246,164 | 262,849 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $58,027,293 | 238,501 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $58,545,347 | 242,103 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $53,365,358 | 237,211 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $56,019,665 | 263,436 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $62,258,137 | 255,418 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $60,872,610 | 244,655 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $89,613,619 | 389,760 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $84,754,989 | 333,471 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $65,468,839 | 277,575 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $51,012,949 | 251,630 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||